Deep tendon reflexes, magnesium, and calcium: Assessments and implications

JOGNN - Journal of Obstetric, Gynecologic, and Neonatal Nursing

Volumn 33, Issue 2, 2004, Pages 221-230

  Nick, Jan M ^a  

^a LOMA LINDA UNIVERSITY   (United States)

Author keywords

Calcium; CNS irritability; DTR; High risk pregnancy; Hypermagnesemia; Hyperreflexia; Hyporeflexia; Magnesium therapy; Magnesium toxicity; Preeclampsia; Pregnancy induced hypertension; Preterm labor; Reflexes

Indexed keywords

ANTIDOTE; CALCIUM CHLORIDE; GLUCONATE CALCIUM; MAGNESIUM SULFATE; UTERUS SPASMOLYTIC AGENT;

ARTICLE; BRADYCARDIA; CLINICAL FEATURE; DRUG BLOOD LEVEL; DRUG COST; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG HALF LIFE; DRUG MECHANISM; DRUG OVERDOSE; DRUG SAFETY; DRUG TISSUE LEVEL; FEMALE; HEART VENTRICLE FIBRILLATION; HUMAN; HYPERMAGNESEMIA; HYPERREFLEXIA; HYPOREFLEXIA; HYPOTENSION; MAGNESIUM BLOOD LEVEL; NURSING; PERINATAL CARE; PHYSICIAN; PREECLAMPSIA; PREMATURE LABOR; RISK ASSESSMENT; SEIZURE; TEAMWORK; TENDON REFLEX; TISSUE NECROSIS; TOCOLYSIS; INTRAVENOUS DRUG ADMINISTRATION; MYOTATIC REFLEX; NEWBORN NURSING; NURSE ATTITUDE; NURSING ASSESSMENT; PREGNANCY; REVIEW; RISK FACTOR; STANDARD;

FEMALE; HUMANS; INFUSIONS, INTRAVENOUS; MAGNESIUM SULFATE; NEONATAL NURSING; NURSE'S ROLE; NURSING ASSESSMENT; OBSTETRIC LABOR, PREMATURE; PRE-ECLAMPSIA; PREGNANCY; REFLEX, STRETCH; RISK FACTORS; TOCOLYTIC AGENTS;

EID: 21244474745     PISSN: 08842175     EISSN: None     Source Type: Journal    
DOI: 10.1177/0884217504263145     Document Type: Article

References (52)

1. Agus, Z. S., & Lau, K. (1995). Disorders of magnesium metabolism. In A. I. Arieff & R. A. DeFronzo (Eds.), Fluid, electrolyte, and acid-base disorders (2nd ed., pp. 475-492). New York: Churchill Livingstone.
2. Alton, B. H., & Lincoln, G. C. (1925). Control of eclampsia convulsions by intraspinal injections of magnesium sulfate. American Journal of Obstetrics and Gynecology, 9, 167-177.
3. American Academy of Pediatrics & the American College of Obstetricians and Gynecologists. (2002). Obstetric and medical complications. In Guidelines for perinatal care (5th ed., pp. 163-185). Elk Grove Village, IL: Author.
4. American College of Obstetricians and Gynecologists. (1996). Hypertension in pregnancy. Technical Bulletin 219. Washington, DC: Author.
5. American College of Obstetricians and Gynecologists. (2001). Chronic hypertension in pregnancy. Practice Bulletin 29. Washington, DC: Author.
6. Auerbach, P. S., & Langenberg, A. (1985). Ventricular fibrillation associated with calcium administration during cardiopulmonary resuscitation. Journal of Emergency Nursing, 11(2), 69-71.
7. Belfort, M. A., & Moise, K. J. (1992). Effect of magnesium sulfate on maternal brain blood flow in pre-eclampsia: A randomized, placebo-controlled study. American Journal of Obstetrics and Gynecology, 167, 661-666.
8. Bryant, G. W., Lehman, G., & Knoefel, P. K. (1939). Action of magnesium on central nervous system and its antagonism by calcium. Journal of Pharmacology and Experimental Therapeutics, 65, 318-321.
9. Cantarino, J. C., Verma, U. L., Visintainer, P. F., Figueroa, R., Klein, S. A., & Tejani, N. A. (1999). Maternal magnesium sulfate and the development of neonatal periventricular leucomalacia and intraventricular hemorrhage. Obstetrics and Gynecology, 93, 396-402.
10. 4 for tocolysis. Clinica Chimica Acta, 285, 191-193.
11. Carey, C., Lee, H., & Woeltje, K. (2001). Mineral and metabolic bone disease. In Washington manual of medical therapeutics (30th ed., pp. 449-451). Philadelphia: Lippincott, Williams & Wilkins.
12. Caritis, S. N., Edelstone, D. I., & Mueller-Heubach, E. (1979). Pharmacologic inhibition of preterm labor. American Journal of Obstetrics and Gynecology, 133, 557-578.
13. Chin, R. L., Garmel, G. M., & Harter, P. M. (1995). Development of ventricular fibrillation after intravenous calcium chloride administration in a patient with supraventricular tachycardia. Annals of Emergency Medicine, 25, 416-419.
14. Chinayon, P. (1998). Clinical management and outcome of eclampsia at Rajavithi Hospital. Journal of the Medical Association of Thailand, 81(8), 579-585.
15. Cruikshank, D. P., Pitkin, R. M., Donnelly, E., & Reynolds, W. A. (1981). Urinary magnesium, calcium and phosphate excretion during magnesium sulfate infusion. Obstetrics and Gynecology, 58, 430-434.
16. Cruikshank, D. P., Pitkin, R. M., Reynolds, W. A., Williams, G. A., & Hargis, G. K. (1979). Effects of magnesium sulfate treatment on perinatal calcium metabolism. American Journal of Obstetrics and Gynecology, 134, 243-249.
17. Dickason, E. J., Silverman, B. L., & Kaplan, J. A. (1998). Hypertensive, embolic, and immune problems during pregnancy. In Maternal-infant nursing care (3rd ed., pp. 580-609). St. Louis: Mosby-Year Book.
18. Frost, L., Danielsen, H., Dorup, I., Kjaer, T., & Pedersen, E. B. (1993). Skeletal muscle magnesium content during cyclosporin and azathioprine treatment in renal transplant recipients. Nephrology, Dialysis, Transplantation, 8, 79-83.
19. Goldenberg, R. L., & Rouse, D. J. (1997). Preterm birth, cerebral palsy, and magnesium. Nature Medicine, 3(2), 146-147.
20. Gray, P. H., O'Callaghan, M. J., Mohay, H. A., Burns, Y. R., & King, J. F. (1998). Maternal hypertension and neurodevelopmental outcome in very preterm infants. Archives of Disease in Childhood - Fetal and Neonatal Edition, 79(2), F88-F93.
21. Guilliams, S., & Held, B. (1979). Contemporary management and conduct of preterm labor and delivery: A review. Obstetrical and Gynecological Survey, 34, 248-255.
22. Hall, D. G. (1957). Serum magnesium in pregnancy. Obstetrics and Gynecology, 9(2), 158-166.
23. Hallet, M. (1993). NINDS myotatic reflex scale. Neurology, 43, 2723.
24. Haigney, M. C., Silver, B., Tanglao, E., Silverman, H. S., Hill, J. D., Shapiro, E., et al. (1995). Noninvasive measurement of tissue magnesium and correlation with cardiac levels. Circulation, 92, 2190-2197.
25. Heckler, F. R., & McCraw, J. B. (1979). Calcium related cutaneous necrosis. Surgical Forum, 27, 553-555.
26. Hypermagnesemia (pharmacologic treatment). (2002). In R. Klasco (Ed.), EMERGINDEX System. Greenwood Village, CO: MICROMEDEX, Inc. (Edition expires June 2002).
27. Kane, H. F. (1926). Eclampsia: Etiology and treatment. Surgery, Gynecology and Obstetrics with International Abstracts of Surgery, 42, 569-571.
28. Lazard, E. M. (1925). Preliminary report on intravenous use of magnesium sulphate in puerperal eclampsia. American Journal of Obstetrics and Gynecology, 9, 178-188.
29. Lu, J. F., & Nightingale, C. H. (2000). Magnesium sulfate in eclampsia and pre-eclampsia. Clinical Pharmacokinetics, 38(4), 305-314.
30. Magnesium sulfate. (2002). In Drug facts and comparisons (56th ed., pp. 1068-1069). St. Louis: Wolter Kluwer.
31. Matz, R. (1993). Magnesium: Deficiencies and therapeutic uses. Hospital Practice, 28(4A), 79-82, 85-87, 91-92.
32. Meltzer, S. J., & Auer, J. (1907). Antagonistic action of calcium upon the inhibitory effect of magnesium: A demonstration. Proceedings of the American Physiological Society, 8, xi.
33. Metheny, N. M. (2000). Magnesium imbalances. In Fluid and electrolyte balance: Nursing considerations (4th ed., pp. 130-144). New York: Lippincott, Williams & Wilkins.
34. Mordes, J. P., Swartz, R., & Arky, R. A. (1975). Extreme hypermagnesemia as a cause of refractory hypotension. Annals of Internal Medicine, 83, 657-658.
35. Mordes, J. P., & Wacker, W. E. C. (1978). Excess magnesium. Pharmacological Reviews, 29, 273-300.
36. Naidu, S., Payne, A. J., Moodley, J., Hoffmann, M., & Gouws, E. (1996). Randomized study assessing the effect of phenytoin and magnesium sulphate on maternal cerebral circulation in eclampsia using transcranial Doppler ultrasound. British Journal of Obstetrics and Gynaecology, 103, 111-116.
37. Nick, J. M. (2003). Deep tendon reflexes: The what, why, where, and how of tapping. Journal of Obstetric, Gynecologic, and Neonatal Nursing, 32, 297-306.
38. Niebyl, J. R., & Johnson, J. W. (1980). Inhibition of preterm labor. Clinical Obstetrics and Gynecology, 23, 115-126.
39. Olds, S. B., London, M. L., Ladewig, P., & Davidson, M. R. (2004). Pregnancy at risk: Gestational onset. In Maternal-newborn nursing: A family and community-based approach (7th ed., pp. 467-524). Upper Saddle River, NJ: Prentice Hall Health.
40. Pritchard, J. A. (1979). The use of magnesium sulfate in preeclampsia-eclampsia. Journal of Reproductive Medicine, 23, 107-114.
41. Raman, N. V., & Rao, C. A. (1995). Magnesium sulfate as an anticonvulsant in eclampsia. International Journal of Gynaecology and Obstetrics, 49, 289-298.
42. Romano, T. J. (1997). Serum magnesium levels may not indicate low tissue magnesium levels. Archives of Internal Medicine, 157, 460.
43. Rubin, R. P. (1970). The role of calcium in the release of neurotransmitter substances and hormones. Pharmacological Reviews, 22, 389-428.
44. Rude, R. K. (1996). Magnesium disorders. In J. P. Kokko & R. L. Tannen (Eds.), Fluids and electrolytes (3rd ed., pp. 421-445). Philadelphia: W. B. Saunders.
45. Semple, P., & Booth, C. (1996). Calcium chloride: A reminder. Anesthesia, 51, 93.
46. Shah, B. R., Santucci, K., & Finberg, L. (1994). Magnesium deficiency as a cause of hypocalcemia in the CHARGE association. Archives of Pediatrics and Adolescent Medicine, 148, 486-489.
47. Sibai, B. M. (1990). Magnesium sulfate is the ideal anticonvulsant in preeclampsia-eclampsia. American Journal of Obstetrics and Gynecology, 162, 1141-1145.
48. Sibai, B. M. (1996). Hypertension in pregnancy. In S. Gabbe, J. Niebyl, & J. Simpson (Eds.), Obstetrics: Normal and problem pregnancies (3rd ed., pp. 935-996). New York: Churchill Livingstone.
49. Sisson, M. C., & Sauer, P. M. (1995). Pharmacologic therapy for pregnancy-induced hypertension. Journal of Perinatal and Neonatal Nursing, 9(4), 1-12.
50. Spratto, G. R., & Woods, A. L. (2000). PDR nurse's drug handbook. Montvale, NJ: Delmar.
51. Thomas, C. L. (Ed.). (1997). Taber's cyclopedic medical dictionary (18th ed.). Philadelphia: F. A. Davis.
52. Wilson, K. M. (1925). Comparison of the results obtained after radical and conservative treatment of eclampsia in the obstetrical department of the Johns Hopkins Hospital. American Journal of Obstetrics and Gynecology, 9, 189-197.